نتایج جستجو برای: rabeprazole sodium
تعداد نتایج: 187990 فیلتر نتایج به سال:
Proton-pump inhibitors (PPIs) are widely used to treat acid-related disorders (ARD). Rabeprazole is a potent inhibitor of gastric H+/K+-ATPase, and it indicated for the treatment gastroesophageal reflux disease, Zollinger-Ellison syndrome, duodenal ulcers Helicobacter pylori eradication (in combination with antibiotics), as well ARD described in this article. Pharmacokinetic pharmacodynamic dat...
Rabeprazole sodium (RAB) is an anti-secretory agent which inhibits the enzyme H+/K+ ATPase, present in the stomach parietal cells. The aim of this work is to develop and validate a simple and fast ultraviolet spectrophotometric method (UV) for quantification of RAB in pharmaceutical formulation and compare it with a capillary electrophoresis (CE) one, previously validated. The UV technique was ...
یک سری پنج تایی لیگاند چهار دندانه سولفور دهنده: en-bis-dtcna = ethylenebisdithiocarbamate sodium salt pn-bis-dtcna = propylenebisdithiocarbamate sodium salt bu-bis-dtcna = butylenebisdithiocarbamate sodium salt he-bis-dtcna = hexylenebisdithiocarbamate sodium salt oc-bis-dtcna = octylenebisdithiocarbamate sodium salt تهیه شده است. این لیگاندها به روش های ir ,1h-nmr و تجزیه عنصری شن...
BACKGROUND Dual therapy with aspirin and clopidogrel increases the risk of gastrointestinal bleeding. Therefore, co-therapy with a proton pump inhibitor (PPI) is recommended by most guidelines. However, there are warnings against combining PPIs with clopidogrel because of their interactions with cytochrome P450 isoenzyme 2C19 (CYP2C19). METHODS The effects of the combined or separate intake o...
Proton-pump inhibitors (PPIs) have been proved as safe and effective ways to treat patients with non-erosive reflux disease (NERD). However, less is known about the comparisons among different PPIs and their best dosage. We aimed to synthesize the available evidence through network meta-analysis to investigate the efficacy and safety of different PPIs in treating patients with NERD. Fifteen stu...
The objective of the study was to document practice pattern of gastroenterologists for the management of gastroesophageal reflux disease (GERD) under the minimal influence of the insurance reimbursement guideline. Data on management for 1,197 consecutive patients with typical GERD symptoms were prospectively collected during 16 weeks. In order to minimize the influence of reimbursement guidelin...
A 59-year-old man was orally administered rabeprazole, a proton pump inhibitor (PPI), for gastroesophageal reflux disease, after which he gradually developed iron-deficiency anemia. The anemia did not improve following the administration of ferrous fumarate, and endoscopic screening of the entire gastrointestinal tract, including the small intestine, did not reveal any findings indicating the c...
Severe hypomagnesemia is a serious clinical condition. Proton pump inhibitor (PPI) induced hypomagnesemia has been recognized since 2006. In March 2011 the U.S. Food and Drug Administration advised that long-term use of PPI can induce hypomagnesemia. We report the first Japanese case of hypomagnesemia associated with chronic use of PPIs in a 64-year-old man hospitalized for nausea, bilateral an...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید